Cue Health Inc
OTC:HLTHQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Cue Health Inc
Revenue
Cue Health Inc
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Cue Health Inc
OTC:HLTHQ
|
Revenue
$70.9m
|
CAGR 3-Years
46%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$20.6B
|
CAGR 3-Years
16%
|
CAGR 5-Years
15%
|
CAGR 10-Years
10%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Revenue
$6.3B
|
CAGR 3-Years
5%
|
CAGR 5-Years
7%
|
CAGR 10-Years
9%
|
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$25.1B
|
CAGR 3-Years
11%
|
CAGR 5-Years
12%
|
CAGR 10-Years
10%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$45.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$10.1B
|
CAGR 3-Years
17%
|
CAGR 5-Years
18%
|
CAGR 10-Years
15%
|
|
Cue Health Inc
Glance View
Cue Health, Inc. is a healthcare technology company which offers individuals, enterprises, government agencies, and healthcare providers access to lab-quality diagnostic testing at home, at work, or at the point-of-care, all in a device. The company is headquartered in San Diego, California. The company went IPO on 2021-09-24. The firm has developed a platform, the Cue Integrated Care Platform, with a focus on user experience, convenience, and accuracy. The Cue Integrated Care Platform consists of hardware and software components: Cue Health Monitoring System includes Cue Reader, made up of a portable, durable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand a sample collection wand; Cue Data and Innovation Layer, with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, including its consumer-friendly Cue Health App and its Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, which allow for integrations with third-party applications and sensors. Its product offering is Cue COVID-19 Test. Its COVID-19 test, consist Cue Reader and COVID-19 Test Kit (Cue COVID-19 Cartridge and Cue Wand), is designed to detect SARS-CoV-2, the virus that causes COVID-19.
See Also
What is Cue Health Inc's Revenue?
Revenue
70.9m
USD
Based on the financial report for Dec 31, 2023, Cue Health Inc's Revenue amounts to 70.9m USD.
What is Cue Health Inc's Revenue growth rate?
Revenue CAGR 3Y
46%
Over the last year, the Revenue growth was -85%. The average annual Revenue growth rates for Cue Health Inc have been 46% over the past three years .